Mandate

Vinge has advised Gränges in connection with its rights issue

Vinge has advised Gränges AB (publ) in connection with a fully guaranteed rights issue of approximately SEK 1.7 billion before transaction costs.

The purpose of the rights issue is to finance the acquisition of Aluminium Konin, maintain Gränges’ financial strength and to finance future growth investments in line with Gränges’ strategy. The new shares subscribed for with subscription rights are expected to be admitted to trading on Nasdaq Stockholm on December 22, 2020.

Gränges is a leading global supplier of rolled aluminium products for heat exchanger applications, speciality packaging and niche markets. The company develops, produces and markets advanced materials that enhance efficiency in the customers’ manufacturing process and the performance of the final products. The company’s geographical markets are Europe, Asia and the Americas with production facilities in all three regions and a total annual capacity of 560,000 metric tonnes. Gränges has 2,400 employees and net sales of SEK 13 billion. The share is listed on Nasdaq Stockholm.

Vinge’s team primarily consisted of Jesper Schönbeck, Rikard Lindahl, Linnéa Sellström, Stephanie Stiernstedt, Anders Sundin Lundberg and Lorin Arabi (Capital Markets and Public M&A), Pauline Lagerstrand and Rebecka Målquist (Banking and Finance) as well as Maria Schultzberg and Henrik Wastenson (Tax).

Related

Vinge advises Fortinova Fastigheter AB (publ) on its first SEK 200 million green bond issue

Vinge has advised Fortinova Fastigheter AB (publ) (“Fortinova”) on the company’s first issue of senior unsecured green bonds in an aggregate principal amount of SEK 200 million, under a framework of up to SEK 600 million. Nordea, acted as sole bookrunner in connection with the bond issue.
September 18, 2026

Vinge advises Morrow Bank AB (publ) in connection with the bank’s sale of parts of MedMera Bank and the sale of NPL portfolios

Vinge has advised Morrow Bank AB (publ) in connection with the divestment of parts of MedMera Bank’s operations to a leading global credit investment firm. The divestment is structured as a sale of shares and priced at a premium of approximately SEK 90 million above equity value as per the completion date. The transaction includes parts of MedMera’s banking operations such as IT infrastructure, organisation and management, whilst Morrow Bank retains MedMera’s performing loans, deposits, customers, the MedMera brand, the Coop partnership agreement as well as key personnel.
September 15, 2026

Vinge advises HealthCap in conjunction with its investment in AMRA Medical

HealthCap is investing in AMRA Medical AB, a company that analyses whole-body MRI images to classify and quantify an individual’s muscle and fat tissue throughout the body and places this in relation to human health and disease.
September 15, 2026